The Power of STB CLOUD in Remote AI Drug Discovery
STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery …
Biopharma Insights
AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning
The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several …
RetinAI and Boehringer Ingelheim Collaborate on AI-Driven Drug Discovery for Geographic Atrophy Treatment
Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and …
Myricx Pharma Showcases Promising Pre-Clinical Data for NMTi ADC Programme at AACR
Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented …
Enamine and Endogena's Persistent Collaboration Paves the Way for Regenerative Medicine Advancements
In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and …
Macomics Unveils ENIGMAC™ Discovery Platform at AACR for Target Validation in Macrophage Therapies
Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American …
FDA Collaborates with Cerner Enviza and John Snow Labs to Harness AI and EHR Data Analytics for Pharmacovigilance
Cerner Enviza, an Oracle company, and John Snow Labs have been selected by the FDA's Sentinel Innovation Center to support …
PsychoGenics Introduces eCube, an AI-Driven Platform for Drug Discovery in Neuropsychiatric Disorders
PsychoGenics, a prominent player in AI-enabled phenotypic drug discovery and preclinical CRO services, has recently unveiled eCube, an innovative pharmaco-electroencephalography …
Some Drugs That Improve Price Competition Fall Through The Cracks Of FDA User Fees
Americans are increasingly concerned about rising drug prices. FDA user fees affect drug pricing competition, which is often overlooked. FDA …
ConcertAI Unveils Next-Generation Clinical Trial Optimization Platform, CTO 2.0
ConcertAI, an AI Software-as-a-Service (SaaS) and Real-World Evidence (RWE) solutions provider for the life sciences and healthcare sectors, recently announced …
Introducing “Lab-on-a-Molecule” Drug Discovery Approach via DNA Nanoswitches
The challenge faced by current compound screening approaches often lies in their limitations, either in throughput or their capacity to …
Introducing PathExplore, a Game-Changing AI Tool for In-Depth Tumor Microenvironment Exploration
As we continue to make progress in oncology therapeutics, researchers are constantly seeking ways to improve patient outcomes by understanding …